Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice.

Yu, Zhi-hong

Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice. [electronic resource] - Biological & pharmaceutical bulletin 2012 - 731-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1347-5215

10.1248/bpb.35.731 doi


Actins--metabolism
Animals
Bleomycin
Blotting, Western
Cell Proliferation--drug effects
Collagen--metabolism
Fibroblast Growth Factors--metabolism
Fibroblasts--cytology
Lung--drug effects
Male
Mice
Mice, Inbred C57BL
Mitogen-Activated Protein Kinases--metabolism
Peptide Fragments--pharmacology
Pulmonary Fibrosis--chemically induced
Receptor, Fibroblast Growth Factor, Type 2--pharmacology
Receptors, Fibroblast Growth Factor--metabolism
Recombinant Proteins--pharmacology
Smad3 Protein--metabolism
Transforming Growth Factor beta1--metabolism